Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | CDK8 | P49336 | 2/20 | 0.35 |
| ▸ | HTR2A | P28223 | 1/20 | 0.34 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.34 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.34 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.33 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.33 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.33 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.33 |
| ▸ | TAS1R2 | Q8TE23 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | VNN1 | O95497 | 4/20 | 0.32 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17352172 | 0.89 | HTR2A (0.36) | CDK8HTR2ASLC6A4KCNH2EPHX2 | |
| SCHEMBL17356506 | 0.86 | PTPN7 (0.40) | CDK8HTR2ASLC6A4KCNH2EPHX2 | |
| SCHEMBL17355838 | 0.86 | NPC1 (0.36) | SMN1; SMN2KDM4EALDH1A1 | |
| SCHEMBL17352120 | 0.86 | HTR2A (0.39) | CDK8HTR2ASLC6A4KCNH2EPHX2 | |
| SCHEMBL17356492 | 0.85 | GAA (0.39) | — | |
| SCHEMBL17356491 | 0.82 | TRPM8 (0.38) | CDK8HTR2ASLC6A4KCNH2EPHX2 | |
| SCHEMBL17356405 | 0.79 | CDK8 (0.40) | CDK8HTR2ASLC6A4KCNH2EPHX2 | |
| SCHEMBL17356472 | 0.79 | CDK8 (0.44) | CDK8HTR2ASLC6A4KCNH2EPHX2 | |
| SCHEMBL17352167 | 0.79 | MAPT (0.44) | CDK8HTR2ASLC6A4KCNH2EPHX2 | |
| SCHEMBL17356433 | 0.79 | FFAR1 (0.40) | SMN1; SMN2EPHX2KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150372349-A1 | NON-AQUEOUS ELECTROLYTE AND ELECTRICITY STORAGE DEVICE | UBE INDUSTRIES, LTD. (JP) | 2015-12-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150372349-A1 | NON-AQUEOUS ELECTROLYTE AND ELECTRICITY STORAGE DEVICE | HCN2, SCO2, HCN1 | SMN1; SMN2 3445/4885CDK8 4065/4885HTR2A 4567/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.